References
- Kaufmann SH. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect. Dis.11(8), 633–640 (2011).
- Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet346(8986), 1339–1345 (1995).
- Black GF, Weir RE, Floyd S et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet359(9315), 1393–1401 (2002).
- Lalor MK, Ben-Smith A, Gorak-Stolinska P et al. Population differences in immune responses to bacille Calmette–Guérin vaccination in infancy. J. Infect. Dis.199(6), 795–800 (2009).
- Lalor MK, Floyd S, Gorak-Stolinska P et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J. Infect. Dis.204(7), 1075–1085 (2011).
- Soares AP, Scriba TJ, Joseph S et al. Bacillus Calmette–Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol.180(5), 3569–3577 (2008).
- Hanekom WA, Dockrell HM, Ottenhoff TH et al. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Med.5(7), e145 (2008).
- Elias D, Akuffo H, Britton S. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans. R. Soc. Trop. Med. Hyg.99(5), 363–368 (2005).
- Badell E, Nicolle F, Clark S et al. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine27(1), 28–37 (2009).
- Kagina BM, Abel B, Scriba TJ et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am. J. Respir. Crit. Care Med.182(8), 1073–1079 (2010).
- Joosten SA, Goeman JJ, Sutherland JS et al. Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun. doi:10.1038/gene.2011.64 (2011) (Epub ahead of print).
- Berry MP, Graham CM, McNab FW et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature466(7309), 973–977 (2010).
- Kagina BM, Abel B, Bowmaker M et al. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine27(40), 5488–5495 (2009).
- Burl S, Adetifa UJ, Cox M et al. Delaying bacillus Calmette–Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J. Immunol.185(4), 2620–2628 (2010).
- Djuardi Y, Sartono E, Wibowo H, Supali T, Yazdanbakhsh M. A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses. PLoS One5(11), e14066 (2010).
- Djuardi Y, Wammes LJ, Supali T, Sartono E, Yazdanbakhsh M. Immunological footprint: the development of a child’s immune system in environments rich in microorganisms and parasites. Parasitology138(12), 1508–1518 (2011).
- Colditz GA, Berkey CS, Mosteller F et al. The efficacy of bacillus Calmette–Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics96(1 Pt 1), 29–35 (1995).
- Salzman NH. Microbiota-immune system interaction: an uneasy alliance. Curr. Opin. Microbiol.14(1), 99–105 (2011).
Websites
- WHO Report. Global tuberculosis control 2011. http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf (Accessed 24 November 2011)
- Stop TB Partnership: an international roadmap for tuberculosis research (2011). www.stoptb.org/assets/documents/resources/publications/technical/tbresearchroadmap.pdf (Accessed 24 November 2011)